FDA Brief

Warning letters Biologics

FDA warning letter to

Kimera Labs, Inc.

Issued Sep 1, 2023Posted Jan 4, 2024Division of Biological Products Operations I

Investigational Device Exemptions (IDE). We haven't summarized this letter yet. Read it on fda.gov.